DK58887D0 - AUTO ANTIGEN VACCINER - Google Patents

AUTO ANTIGEN VACCINER

Info

Publication number
DK58887D0
DK58887D0 DK058887A DK58887A DK58887D0 DK 58887 D0 DK58887 D0 DK 58887D0 DK 058887 A DK058887 A DK 058887A DK 58887 A DK58887 A DK 58887A DK 58887 D0 DK58887 D0 DK 58887D0
Authority
DK
Denmark
Prior art keywords
vacciner
auto antigen
antigen
auto
antigen vacciner
Prior art date
Application number
DK058887A
Other languages
Danish (da)
Other versions
DK58887A (en
Inventor
Karen D Talmadge
John C Fiddes
Original Assignee
Biotech Res Partners Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotech Res Partners Ltd filed Critical Biotech Res Partners Ltd
Publication of DK58887D0 publication Critical patent/DK58887D0/en
Publication of DK58887A publication Critical patent/DK58887A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/035—Fusion polypeptide containing a localisation/targetting motif containing a signal for targeting to the external surface of a cell, e.g. to the outer membrane of Gram negative bacteria, GPI- anchored eukaryote proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Reproductive Health (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Seeds, Soups, And Other Foods (AREA)
DK058887A 1985-06-04 1987-02-04 AUTO ANTIGEN VACCINER DK58887A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US74116885A 1985-06-04 1985-06-04
US75684785A 1985-07-18 1985-07-18
PCT/US1986/001226 WO1986007383A1 (en) 1985-06-04 1986-06-04 Autoantigen vaccines

Publications (2)

Publication Number Publication Date
DK58887D0 true DK58887D0 (en) 1987-02-04
DK58887A DK58887A (en) 1987-04-03

Family

ID=27113816

Family Applications (1)

Application Number Title Priority Date Filing Date
DK058887A DK58887A (en) 1985-06-04 1987-02-04 AUTO ANTIGEN VACCINER

Country Status (5)

Country Link
EP (1) EP0224574A4 (en)
KR (1) KR880700077A (en)
AU (1) AU5993186A (en)
DK (1) DK58887A (en)
WO (1) WO1986007383A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5420113A (en) * 1986-09-12 1995-05-30 Kyowa Hakko Kogyo Co., Ltd. [Leu13]motilin, DNAs coding for same and methods for producing same
JP2862870B2 (en) * 1986-09-12 1999-03-03 協和醗酵工業株式会社 New peptide
US5695952A (en) * 1986-09-12 1997-12-09 Kyowa Hakko Kogyo Co., Ltd. Method for producing Leu13 !motilin
FR2623715B1 (en) * 1987-11-26 1990-12-21 Lafon Labor PEPTIDE STRUCTURES, IMMUNOGENS CONTAINING THEM AND THEIR APPLICATIONS IN FERTILITY CONTROL
IL91462A0 (en) * 1988-08-30 1990-04-29 Applied Research Systems Recombinant fusion proteins and dna encoding for such a protein
CA1340762C (en) * 1989-09-29 1999-09-21 National Institute Of Immunology Recombinant birth control vaccine
US5733553A (en) * 1989-09-29 1998-03-31 Talwar; Gursaran Prasad Recombinant birth control vaccine
US5723129A (en) * 1991-10-16 1998-03-03 University Of Saskatchewan GnRH-leukotoxin chimeras
US5837268A (en) 1991-10-16 1998-11-17 University Of Saskatchewan GnRH-leukotoxin chimeras
WO1994015633A1 (en) * 1992-12-31 1994-07-21 The International Development Research Centre ANTI-CANCER UTILITY OF hCG VACCINES
US5762931A (en) * 1992-12-31 1998-06-09 National Institute Of Immunology Anti-cancer utility of HCG vaccines
US5688506A (en) * 1994-01-27 1997-11-18 Aphton Corp. Immunogens against gonadotropin releasing hormone
DE69918146T2 (en) 1998-10-05 2005-07-07 Pharmexa A/S METHOD FOR THERAPEUTIC VACCINATION
US20020025939A1 (en) * 1998-12-18 2002-02-28 Patrick L. Iversen Chorionic gonadortropin dna vaccines and methods
CN1108820C (en) * 1999-11-12 2003-05-21 清华大学 Preparation of epitope vaccine with single monoepitope or multiple monoepitope duplication
MXPA05011965A (en) 2003-05-09 2006-02-02 Pharmexa As Detoxified tnf and method of preparing.
WO2005042575A2 (en) * 2003-10-30 2005-05-12 Pharmexa A/S Method for down-regulation of vegf
EP1716419A2 (en) * 2004-02-20 2006-11-02 AplaGen GmbH Method for the detection of autoantibodies against specific peptides and its use in diagnosis and treatment of pregnancy-loss or infertility.
US20160024181A1 (en) 2013-03-13 2016-01-28 Moderna Therapeutics, Inc. Long-lived polynucleotide molecules
CN116063576A (en) * 2022-11-16 2023-05-05 安徽农业大学 FSHR-DTT recombinant castration vaccine, and preparation method and application thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2068971B (en) * 1980-01-30 1983-06-08 Searle & Co Recombinant dna techniques
US4840896A (en) * 1983-11-02 1989-06-20 Integrated Genetics, Inc. Heteropolymeric protein
DE3486474T2 (en) * 1983-11-02 2000-08-03 Applied Research Systems Products and methods for the production of a heterodimeric human LH with a Met42 Val55 alpha subunit
NZ213759A (en) * 1984-10-19 1989-01-27 Genentech Inc Lhrh-ctp protein conjugates influencing prolactin fsh and lh release

Also Published As

Publication number Publication date
EP0224574A1 (en) 1987-06-10
KR880700077A (en) 1988-02-15
WO1986007383A1 (en) 1986-12-18
DK58887A (en) 1987-04-03
EP0224574A4 (en) 1988-04-26
AU5993186A (en) 1987-01-07

Similar Documents

Publication Publication Date Title
DK398887D0 (en) ANTIBODIES
DK58887D0 (en) AUTO ANTIGEN VACCINER
BR8601646A (en) DOORMAT
DK307986A (en) CLONET ANTIGEN
KR870700633A (en) Recombinable Inhibin
KR870009181U (en) Small motor
DK172686D0 (en) ANTIGEN
DK190889A (en) ANTIGEN
ATA370685A (en) SHUTDLE ELEMENT
KR870003017U (en) Small motor
ATA155686A (en) GIESSPFANENKOPF
DK612786D0 (en) IMMUNO STRENGTHENER
IT1197123B (en) DOWN
AT386920B (en) MAISHAECKSLER
ATA122686A (en) CHAINLOCK
DK554986D0 (en) ANTIBODY
KR870011398U (en) Small motor
DK554886A (en) ANTIBODIES
KR900015577U (en) Automotive sunshade
ATA173385A (en) STIEGENLIFT
KR860014647U (en) Automobile
SE8505460D0 (en) VEHICLE
SE8500739D0 (en) VEHICLE
DK353288D0 (en) ANTIBODIES
DK348888D0 (en) ANTIBODIES